4-Chloro-N-methylpicolinamide

GTC-160

Pharmaceutical Intermediates

4-Chloro-N-methylpicolinamide

CAS No.
220000-87-3
Catalogue ID
GTC-160

4-Chloro-N-methylpicolinamide, CAS 220000-87-3. Source-derived identification, physical data and applications are provided for catalogue reference; request the current specification, COA and SDS for the required grade.

Catalogue aliases / related identifiers

4-Chloro-N-methylpyridine-2-carboxamide; 4-Chloro-N-methyl-2-pyridinecarboxamide; N-Methyl-4-chloropyridine-2-carboxamide; N-Methyl-4-chloropicolinamide; 4-Chloropicolinic acid N-methylamide; Sorafenib INT3; 4-Chloro-N-methyl-2-pyridinamide

Supplied catalogue source: GTC-160 · Page 97

Reference data — confirm before ordering or use

The information below is a structured migration from the supplied catalogue snapshot. It is not a current product specification, COA or SDS. Confirm the actual supplier, grade, batch documents, classification, packing and destination requirements for your enquiry.

4-Chloro-N-methylpicolinamide is a chlorinated pyridine derivative with an N-methyl carboxamide substituent. This structure enables selective nucleophilic aromatic substitution in multi-step synthetic pathways.


Basic Information

CAS No.220000-87-3
EC No.606-888-1
Linear FormulaC7H7ClN2O
Molecular Weight170.60
AppearancePale yellow to white solid / powder
Melting Point41-43 °C (lit.)
Boiling point317.8±27.0 °C (Predicted)
Density1.264±0.06 g/cm³ (Predicted)
SolubilitySoluble in methanol; slightly soluble in common organic solvents (typical reference)
Storage ConditionsKeep in dark place, sealed in dry, room temperature
Chemical StructureMolecular Structure of 4-Chloro-N-methylpicolinamide

Key Applications

  • Pharmaceutical intermediate: A critical precursor in the synthesis of sorafenib, a multi-kinase inhibitor for oncology applications, and an important building block within Gefitinib, Sunitinib and Sorafenib intermediates for targeted therapy development.

  • API intermediate: Used in the preparation of active pharmaceutical ingredients involving substituted pyridine scaffolds, especially among oncology drug intermediates for anticancer API synthesis.

  • Heterocyclic synthesis: Facilitates construction of pyridine-based aromatic systems through amide and chloro group transformations in pharmaceutical and fine chemical synthesis.

  • Process development: Employed in route optimization and scale-up for efficient production of fine chemical intermediates and downstream pharmaceutical building blocks.

  • Custom synthesis: Applied in tailored projects requiring high-purity chlorinated picolinamides for research use and pharmaceutical intermediates for API synthesis.


  • High product consistency: Maintained through strict quality controls and analytical verification for reproducible performance in intermediate synthesis.

  • Stable international supply: Supported by reliable logistics networks for timely delivery to global pharmaceutical and fine chemical clients.

  • Comprehensive documentation: SDS, COA, and other supporting documents supplied as standard to meet regulatory and quality needs.

  • Technical and packaging flexibility: Expert guidance on applications combined with options like 1kg/5kg/25kg packing in fiber drums or customized formats.

Before you order

Confirm the current commercial product record.

Include the required grade or purity, quantity, preferred packing, destination country/port and required document set.

  • 01Current specification
  • 02Batch or sample COA
  • 03Product- and supplier-specific SDS
  • 04Packing and shipping review
Request product review

INQUIRY

INQUIRY